Concord Medical Services (CCM) Competitors

$4.91 0.00 (0.00%)

Closing price 05/22/2026 03:59 PM Eastern

Extended Trading

$4.78 -0.13 (-2.55%)

As of 05/22/2026 04:04 PM Eastern

CCM vs. PARK, PIII, SERA, DCGO, and EUDA

Should you buy Concord Medical Services stock or one of its competitors? MarketBeat compares Concord Medical Services with other companies and stocks that may be similar based on industry, sector, market capitalization, business model, investor interest, or shared news coverage. Companies and stocks commonly compared with Concord Medical Services include Park Dental Partners (PARK), P3 Health Partners (PIII), Sera Prognostics (SERA), DocGo (DCGO), and EUDA Health (EUDA). These companies are all part of the "healthcare" industry.

How does Concord Medical Services compare to Park Dental Partners?

Park Dental Partners (NASDAQ:PARK) and Concord Medical Services (NYSE:CCM) are both small-cap healthcare companies, but which is the better business? We will compare the two companies based on the strength of their media sentiment, valuation, institutional ownership, earnings, profitability, risk, analyst recommendations and dividends.

Company	Net Margins	Return on Equity	Return on Assets
Park Dental Partners	N/A	N/A	N/A
Concord Medical Services	N/A	N/A	N/A

Park Dental Partners presently has a consensus price target of $21.75, indicating a potential upside of 17.06%. Given Park Dental Partners' stronger consensus rating and higher possible upside, equities research analysts clearly believe Park Dental Partners is more favorable than Concord Medical Services.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Park Dental Partners	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	3 Strong Buy rating(s)	3.25
Concord Medical Services	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00

Park Dental Partners has higher revenue and earnings than Concord Medical Services.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Park Dental Partners	$244.49M	0.34	N/A	N/A	N/A
Concord Medical Services	$65.85M	0.32	-$13.27M	N/A	N/A

In the previous week, Park Dental Partners had 6 more articles in the media than Concord Medical Services. MarketBeat recorded 8 mentions for Park Dental Partners and 2 mentions for Concord Medical Services. Park Dental Partners' average media sentiment score of 0.65 beat Concord Medical Services' score of 0.30 indicating that Park Dental Partners is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Park Dental Partners	0 Very Positive mention(s)	1 Positive mention(s)	3 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Concord Medical Services	0 Very Positive mention(s)	1 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral

Summary

Park Dental Partners beats Concord Medical Services on 7 of the 7 factors compared between the two stocks.

How does Concord Medical Services compare to P3 Health Partners?

P3 Health Partners (NASDAQ:PIII) and Concord Medical Services (NYSE:CCM) are both small-cap medical companies, but which is the better stock? We will contrast the two companies based on the strength of their analyst recommendations, profitability, media sentiment, institutional ownership, risk, dividends, valuation and earnings.

In the previous week, P3 Health Partners and P3 Health Partners both had 2 articles in the media. Concord Medical Services' average media sentiment score of 0.30 beat P3 Health Partners' score of 0.25 indicating that Concord Medical Services is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
P3 Health Partners	0 Very Positive mention(s)	0 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral
Concord Medical Services	0 Very Positive mention(s)	1 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral

Concord Medical Services has a net margin of 0.00% compared to P3 Health Partners' net margin of -8.57%. Concord Medical Services' return on equity of 0.00% beat P3 Health Partners' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
P3 Health Partners	-8.57%	-302.33%	-19.99%
Concord Medical Services	N/A	N/A	N/A

Concord Medical Services has lower revenue, but higher earnings than P3 Health Partners.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
P3 Health Partners	$1.46B	0.07	-$147.95M	-$38.60	N/A
Concord Medical Services	$65.85M	0.32	-$13.27M	N/A	N/A

P3 Health Partners currently has a consensus target price of $14.00, suggesting a potential upside of 6.06%. Given P3 Health Partners' stronger consensus rating and higher probable upside, analysts plainly believe P3 Health Partners is more favorable than Concord Medical Services.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
P3 Health Partners	1 Sell rating(s)	2 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.00
Concord Medical Services	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00

P3 Health Partners has a beta of 0.48, indicating that its stock price is 52% less volatile than the broader market. Comparatively, Concord Medical Services has a beta of -1.09, indicating that its stock price is 209% less volatile than the broader market.

7.8% of P3 Health Partners shares are owned by institutional investors. 17.8% of P3 Health Partners shares are owned by insiders. Comparatively, 46.5% of Concord Medical Services shares are owned by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company will outperform the market over the long term.

Summary

Concord Medical Services beats P3 Health Partners on 7 of the 13 factors compared between the two stocks.

How does Concord Medical Services compare to Sera Prognostics?

Sera Prognostics (NASDAQ:SERA) and Concord Medical Services (NYSE:CCM) are both small-cap medical companies, but which is the superior business? We will compare the two companies based on the strength of their valuation, analyst recommendations, risk, media sentiment, dividends, earnings, institutional ownership and profitability.

54.6% of Sera Prognostics shares are held by institutional investors. 11.3% of Sera Prognostics shares are held by insiders. Comparatively, 46.5% of Concord Medical Services shares are held by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock is poised for long-term growth.

In the previous week, Concord Medical Services had 2 more articles in the media than Sera Prognostics. MarketBeat recorded 2 mentions for Concord Medical Services and 0 mentions for Sera Prognostics. Concord Medical Services' average media sentiment score of 0.30 beat Sera Prognostics' score of 0.00 indicating that Concord Medical Services is being referred to more favorably in the news media.

Company	Overall Sentiment
Sera Prognostics	Neutral
Concord Medical Services	Neutral

Concord Medical Services has a net margin of 0.00% compared to Sera Prognostics' net margin of -56,385.97%. Concord Medical Services' return on equity of 0.00% beat Sera Prognostics' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Sera Prognostics	-56,385.97%	-41.02%	-30.95%
Concord Medical Services	N/A	N/A	N/A

Concord Medical Services has higher revenue and earnings than Sera Prognostics.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Sera Prognostics	$80K	1,013.27	-$31.93M	-$0.65	N/A
Concord Medical Services	$65.85M	0.32	-$13.27M	N/A	N/A

Sera Prognostics has a beta of 0.92, suggesting that its stock price is 8% less volatile than the broader market. Comparatively, Concord Medical Services has a beta of -1.09, suggesting that its stock price is 209% less volatile than the broader market.

Sera Prognostics currently has a consensus price target of $5.00, suggesting a potential upside of 141.55%. Given Sera Prognostics' stronger consensus rating and higher possible upside, equities analysts plainly believe Sera Prognostics is more favorable than Concord Medical Services.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Sera Prognostics	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	1 Strong Buy rating(s)	2.50
Concord Medical Services	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00

Summary

Concord Medical Services beats Sera Prognostics on 8 of the 14 factors compared between the two stocks.

How does Concord Medical Services compare to DocGo?

Concord Medical Services (NYSE:CCM) and DocGo (NASDAQ:DCGO) are both small-cap medical companies, but which is the superior stock? We will compare the two businesses based on the strength of their media sentiment, institutional ownership, profitability, dividends, earnings, analyst recommendations, valuation and risk.

Concord Medical Services has higher earnings, but lower revenue than DocGo.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Concord Medical Services	$65.85M	0.32	-$13.27M	N/A	N/A
DocGo	$322.20M	0.19	-$182.40M	-$1.91	N/A

DocGo has a consensus price target of $2.38, indicating a potential upside of 276.69%. Given DocGo's stronger consensus rating and higher possible upside, analysts clearly believe DocGo is more favorable than Concord Medical Services.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Concord Medical Services	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00
DocGo	1 Sell rating(s)	2 Hold rating(s)	3 Buy rating(s)	0 Strong Buy rating(s)	2.33

Concord Medical Services has a beta of -1.09, suggesting that its share price is 209% less volatile than the broader market. Comparatively, DocGo has a beta of 1.02, suggesting that its share price is 2% more volatile than the broader market.

Concord Medical Services has a net margin of 0.00% compared to DocGo's net margin of -62.23%. Concord Medical Services' return on equity of 0.00% beat DocGo's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Concord Medical Services	N/A	N/A	N/A
DocGo	-62.23%	-44.09%	-29.14%

56.4% of DocGo shares are owned by institutional investors. 46.5% of Concord Medical Services shares are owned by company insiders. Comparatively, 3.8% of DocGo shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock is poised for long-term growth.

In the previous week, Concord Medical Services had 1 more articles in the media than DocGo. MarketBeat recorded 2 mentions for Concord Medical Services and 1 mentions for DocGo. Concord Medical Services' average media sentiment score of 0.30 beat DocGo's score of 0.00 indicating that Concord Medical Services is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Concord Medical Services	0 Very Positive mention(s)	1 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral
DocGo	0 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral

Summary

Concord Medical Services beats DocGo on 8 of the 14 factors compared between the two stocks.

How does Concord Medical Services compare to EUDA Health?

EUDA Health (NASDAQ:EUDA) and Concord Medical Services (NYSE:CCM) are both small-cap medical companies, but which is the better business? We will contrast the two businesses based on the strength of their media sentiment, analyst recommendations, profitability, valuation, institutional ownership, dividends, risk and earnings.

EUDA Health has higher earnings, but lower revenue than Concord Medical Services.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
EUDA Health	$6.82M	6.41	-$2.77M	-$2.40	N/A
Concord Medical Services	$65.85M	0.32	-$13.27M	N/A	N/A

EUDA Health currently has a consensus target price of $55.00, suggesting a potential upside of 216.82%. Given EUDA Health's stronger consensus rating and higher probable upside, equities analysts clearly believe EUDA Health is more favorable than Concord Medical Services.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
EUDA Health	1 Sell rating(s)	1 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.00
Concord Medical Services	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00

In the previous week, Concord Medical Services had 2 more articles in the media than EUDA Health. MarketBeat recorded 2 mentions for Concord Medical Services and 0 mentions for EUDA Health. Concord Medical Services' average media sentiment score of 0.30 beat EUDA Health's score of 0.00 indicating that Concord Medical Services is being referred to more favorably in the news media.

Company	Overall Sentiment
EUDA Health	Neutral
Concord Medical Services	Neutral

4.4% of EUDA Health shares are owned by institutional investors. 46.5% of Concord Medical Services shares are owned by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock will outperform the market over the long term.

Company	Net Margins	Return on Equity	Return on Assets
EUDA Health	N/A	N/A	N/A
Concord Medical Services	N/A	N/A	N/A

EUDA Health has a beta of 0.56, suggesting that its stock price is 44% less volatile than the broader market. Comparatively, Concord Medical Services has a beta of -1.09, suggesting that its stock price is 209% less volatile than the broader market.

Summary

EUDA Health beats Concord Medical Services on 7 of the 11 factors compared between the two stocks.

Get Concord Medical Services News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding CCM and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

CCM vs. The Competition

Export

Metric	Concord Medical Services	MED Industry	Medical Sector	NYSE Exchange
Market Cap	$21.32M	$4.08B	$6.45B	$23.20B
Dividend Yield	N/A	0.73%	2.76%	4.10%
P/E Ratio	N/A	13.23	21.22	30.65
Price / Sales	0.32	1.33	553.92	24.50
Price / Cash	2.64	18.75	43.49	25.12
Price / Book	0.08	2.37	10.37	4.74
Net Income	-$13.27M	$47.01M	$3.57B	$1.07B
7 Day Performance	-1.70%	-1.11%	6.01%	1.45%
1 Month Performance	25.70%	6.43%	3.52%	1.58%
1 Year Performance	-31.71%	46.43%	34.13%	28.44%

Concord Medical Services Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
CCM Concord Medical Services	0.6982 of 5 stars	$4.91 flat	N/A	-31.7%	$21.32M	$65.85M	N/A	970
PARK Park Dental Partners	3.1418 of 5 stars	$18.25 -2.9%	$21.75 +19.2%	N/A	$84.84M	$244.49M	N/A	1,208	High Trading Volume
PIII P3 Health Partners	1.3722 of 5 stars	$9.69 -7.6%	$10.33 +6.6%	+80.8%	$75.67M	$1.46B	N/A	500	Analyst Forecast Gap Up
SERA Sera Prognostics	2.3697 of 5 stars	$1.76 +1.1%	$5.00 +184.1%	+18.3%	$68.14M	$80K	N/A	120	Gap Down
DCGO DocGo	2.7208 of 5 stars	$0.61 +8.3%	$2.38 +286.9%	-52.9%	$55.95M	$322.20M	N/A	3,568	Gap Down

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NYSE:CCM) was last updated on 5/25/2026 by MarketBeat.com Staff.

From Our Partners

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Concord Medical Services (CCM) Competitors

CCM vs. PARK, PIII, SERA, DCGO, and EUDA

How does Concord Medical Services compare to Park Dental Partners?

Summary

How does Concord Medical Services compare to P3 Health Partners?

Summary

How does Concord Medical Services compare to Sera Prognostics?

Summary

How does Concord Medical Services compare to DocGo?

Summary

How does Concord Medical Services compare to EUDA Health?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

CCM vs. The Competition

Concord Medical Services Competitors List

Related Companies and Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Concord Medical Services (CCM) Competitors

CCM vs. PARK, PIII, SERA, DCGO, and EUDA

How does Concord Medical Services compare to Park Dental Partners?

Is PARK or CCM more profitable?

Do analysts recommend PARK or CCM?

Which has better valuation & earnings, PARK or CCM?

Does the media favor PARK or CCM?

Summary

How does Concord Medical Services compare to P3 Health Partners?

Does the media favor PIII or CCM?

Is PIII or CCM more profitable?

Which has stronger valuation and earnings, PIII or CCM?

Do analysts prefer PIII or CCM?

Which has more risk & volatility, PIII or CCM?

Do insiders & institutionals hold more shares of PIII or CCM?

Summary

How does Concord Medical Services compare to Sera Prognostics?

Do insiders & institutionals hold more shares of SERA or CCM?

Does the media favor SERA or CCM?

Is SERA or CCM more profitable?

Which has better valuation and earnings, SERA or CCM?

Which has more volatility & risk, SERA or CCM?

Do analysts recommend SERA or CCM?

Summary

How does Concord Medical Services compare to DocGo?

Which has stronger earnings & valuation, CCM or DCGO?

Do analysts prefer CCM or DCGO?

Which has more volatility & risk, CCM or DCGO?

Is CCM or DCGO more profitable?

Do insiders & institutionals believe in CCM or DCGO?

Does the media favor CCM or DCGO?

Summary

How does Concord Medical Services compare to EUDA Health?

Which has stronger valuation and earnings, EUDA or CCM?

Do analysts recommend EUDA or CCM?

Does the media refer more to EUDA or CCM?

Do institutionals & insiders hold more shares of EUDA or CCM?

Is EUDA or CCM more profitable?

Which has more risk and volatility, EUDA or CCM?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

CCM vs. The Competition

Concord Medical Services Competitors List

Related Companies and Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools